Update on C3 glomerulopathy

Thomas D Barbour1, Marieta M Ruseva1, Matthew C Pickering1

  • 1Centre for Complement and Inflammation Research (CCIR), Division of Immunology and Inflammation, Department of Medicine, Imperial College London, London W12 0NN, UK.

Insights

C3 glomerulopathy involves abnormal complement system control, leading to kidney damage. Recent research clarifies its causes, focusing on complement factor H-related proteins and potential new treatments.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • C3 glomerulopathy is characterized by excessive C3 fragment deposition in the glomerulus, causing kidney damage.
  • The primary issue is dysregulated complement activation, specifically uncontrolled C3b amplification.
  • Abnormal complement factor H-related (CFHR) proteins are implicated in some cases, potentially by disrupting complement factor H (CFH) regulation.

Purpose of the Study:

  • To summarize recent advancements in understanding C3 glomerulopathy pathogenesis.
  • To highlight updated case definitions and diagnostic recommendations.
  • To review emerging therapeutic strategies for C3 glomerulopathy.

Main Methods:

  • Review of recent clinicopathological cohort studies.
  • Analysis of family studies investigating CFHR protein abnormalities.
  • Synthesis of published clinical experiences with complement-targeted therapies.

Main Results:

  • Uncontrolled C3b amplification is identified as a key pathogenic mechanism.
  • Structurally abnormal CFHR proteins are linked to C3 glomerulopathy through 'CFH de-regulation'.
  • A 2013 consensus report refined case definitions and treatment guidelines.

Conclusions:

  • Understanding of C3 glomerulopathy pathogenesis has significantly improved.
  • Targeted therapies, including C5 inhibitors, show early clinical promise.
  • Continued research is crucial for refining diagnosis and treatment of this rare kidney disease.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
670
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
4
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
533
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
87